In a periodontitis-induced Sprague-Dawley rat model, GH was able to reduce 21.26% of plasma IL-1β and 81.27% of tissue IL-1β, suggesting the potential of GH in periodontal disease treatment. This evidence concerns the gene IL1B and periodontitis.